191 related articles for article (PubMed ID: 37770477)
1. A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs.
Zhang M; Zuo Y; Guo J; Yang L; Wang Y; Tan M; Guo X
Sci Rep; 2023 Sep; 13(1):16332. PubMed ID: 37770477
[TBL] [Abstract][Full Text] [Related]
2. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
3. A promising anoikis-related prognostic signature predicts prognosis of skin cutaneous melanoma.
Yue Z; Wang D; Li X
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17757-17770. PubMed ID: 37930439
[TBL] [Abstract][Full Text] [Related]
4. Development of anoikis-related long non-coding RNA signature associated with prognosis and immune landscape in cutaneous melanoma patients.
Zhong L; Qian W; Gong W; Zhu L; Zhu J
Aging (Albany NY); 2023 Aug; 15(15):7655-7672. PubMed ID: 37543428
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub anoikis-associated genes and risk signature in cutaneous melanoma.
He YW; Fan QP; Hua AL; Liu Q
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5662-5676. PubMed ID: 37401304
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of anoikis-related lncRNAs for prognostic significance and immune microenvironment characterization in ovarian cancer.
Cao L; Zhang S; Peng H; Lin Y; Xi Z; Lin W; Guo J; Wu G; Yu F; Zhang H; Ye H
Aging (Albany NY); 2024 Jan; 16(2):1463-1483. PubMed ID: 38226979
[TBL] [Abstract][Full Text] [Related]
7. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA.
Zhang M; Yang L; Wang Y; Zuo Y; Chen D; Guo X
Sci Rep; 2023 May; 13(1):7299. PubMed ID: 37147395
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
10. Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance.
Lu L; Yu M; Huang W; Chen H; Jiang G; Li G
Libyan J Med; 2023 Dec; 18(1):2220153. PubMed ID: 37300839
[TBL] [Abstract][Full Text] [Related]
11. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
[TBL] [Abstract][Full Text] [Related]
12. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
[TBL] [Abstract][Full Text] [Related]
13. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
14. Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.
Liu J; Luo B; Zhang P; Jiang K; Hou Z; Cao X; Tang J
BMC Cancer; 2023 Aug; 23(1):752. PubMed ID: 37580654
[TBL] [Abstract][Full Text] [Related]
15. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the prognostic significance of anoikis-related lncRNAs in invasive breast cancer: from comprehensive bioinformatics analysis to functional experimental validation.
Dong W; Li J; Zhuang Z
Aging (Albany NY); 2024 Jan; 16(1):402-430. PubMed ID: 38189818
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of molecular subtypes identification based on anoikis-related lncRNAs in castration-resistant prostate cancer.
Chen K; Zhang Y; Li C; Liu Y; Cao Q; Zhang X
Cell Signal; 2024 May; 117():111104. PubMed ID: 38373667
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
19. New algorithms based on autophagy-related lncRNAs pairs to predict the prognosis of skin cutaneous melanoma patients.
Liu Y; Zhang H; Hu D; Liu S
Arch Dermatol Res; 2023 Aug; 315(6):1511-1526. PubMed ID: 36624362
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]